Form 4: Outset Medical CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Outset Medical's CEO, Leslie Trigg, sold 5,645 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- Leslie Trigg, the Chair and CEO of Outset Medical, Inc., sold 5,645 shares of common stock on November 15, 2024.
- The sale was executed at a price of $0.8 per share.
- This transaction was not a discretionary trade but rather a 'sell to cover' transaction to satisfy tax withholding obligations.
- The shares sold were related to the vesting of 14,740 shares of common stock underlying restricted stock units (RSUs) granted on March 15, 2021, January 26, 2022, and January 6, 2023.
- Following the transaction, Leslie Trigg directly owns 904,851 shares of common stock and indirectly owns 8,770 shares through the Trigg Family Trust.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction for tax purposes, not indicative of any significant positive or negative sentiment. It's a neutral event.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.
Comparison to Industry Standards
- Similar 'sell to cover' transactions are common among executives at publicly traded companies, particularly in the technology and healthcare sectors.
- The number of shares sold is relatively small compared to the total holdings of the CEO, suggesting this is a routine tax-related transaction rather than a significant change in the executive's investment position.
- Comparable companies in the medical device industry often have similar stock-based compensation plans for their executives, leading to similar 'sell to cover' transactions.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not indicate any change in the CEO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/15/2021 | Date of one of the RSU grants that triggered the tax obligation. |
| 01/26/2022 | Date of one of the RSU grants that triggered the tax obligation. |
| 01/06/2023 | Date of one of the RSU grants that triggered the tax obligation. |
| 11/15/2024 | Date of the stock sale transaction. |
| 11/18/2024 | Date the Form 4 was signed. |
Keywords
Outset Medical, Leslie Trigg, stock sale, tax obligations, restricted stock units, insider trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.